Stay updated on IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.

Latest updates to the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study page now shows an error message and a minimal HTML structure, indicating the record is currently unavailable.SummaryDifference18%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a new site release is in effect, without altering any study content or data on the page.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a new version of the page content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This represents a new build of the page without altering the study data or content.SummaryDifference0.0%

- Check73 days agoChange DetectedRecruitment status updated to 'No longer looking for participants'. New help sections were added to guide users on reading the study record and joining the study, and the Intervention/Treatment label was updated.SummaryDifference0.4%

- Check81 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a newer page rendering. This appears to be a minor metadata update rather than a substantive content change.SummaryDifference0.0%

Stay in the know with updates to IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.